Schwenzer, H, De Zan, E, Elshani, M, Van Stiphout, R, Kudsy, M, Morris, J, Ferrari, V, Um, I H, Chettle, J, Kazmi, F, Campo, L, Easton, A, Nijman, S, Serpi, M, Symeonides, S, Plummer, R, Harrison, D J, Bond, G & Blagden, S P 2021, ' The novel nucleoside analogue ProTide NUC-7738 overcomes cancer resistance mechanisms in vitro and in a first-in-human Phase 1 clinical trial ', Clinical Cancer Research, pp. clincanres.1652.2021 . https://doi.org/10.1158/1078-0432.CCR-21-1652, https://doi.org/doi: 10.1158/1078-0432.CCR-21-1652